Long-term bisphosphonate treatment of postmenopausal osteoporosis is associated with reduction of bone turnover and might, therefore, have deleterious adverse effects on the repair of microdamage ...

Bisphosphonates are the mainstay of osteoporosis therapy. Extensive clinical evaluation supports their utility in stemming progression of the disease and in reducing fracture risk. In the course ...

Osteoporosis medications assessed by the study investigators included several bisphosphonates (for example, alendronate, clodronate and etidronate); raloxifene; strontium ranelate; and parathyroid ...

If you've been given a diagnosis of osteoporosis your doctor will probably prescribe a bisphosphonate, a class of drugs that helps preserve and build bone. Alendronate (Fosamax, Fosamax Plus D ...

Certain foods can reduce medication effectiveness. Dr. Hasan warns against specific combinations that may hinder treatment ...

How the Medications Work: Most of the medications for osteoporosis work by slowing down your bone losses so that your own bone building cells can get caught up and increase your bone density. Estrogen ...

At the time of the interview, 14 patients were taking a bisphosphonate; the remaining 7 patients were taking no OP medication. For 12 participants, the decision to take, or not take, OP medication ...

Discover top medications for 'treating Osteoporosis'? This page compiles essential information on generic and brand-name drugs specifically used for Osteoporosis treatment.Here, you can explore ...

Osteoporosis, often described as a "silent disease," is characterized by weakened and brittle bones that become increasingly prone to fractures. This condition ...

One of the big problems we're discovering is not that the drugs are a problem ... it doesn't do anything. You take a bisphosphonate 50 percent of the time or less, at the end of a couple of ...

The drugs Fosomax, Actonel, Boniva and Reclast, which are called bisphosphonate drugs have ... condition in somebody on one of these drugs for osteoporosis is extremely low. What we've found ...